Home Newsfeeds UBS Maintains Buy on Five9, Lowers Price Target to $135

UBS Maintains Buy on Five9, Lowers Price Target to $135

UBS analyst Taylor McGinnis maintains Five9 (NASDAQ:FIVN) with a Buy and lowers the price target from $180 to $135.

byBenzinga Newsdesk

July 25, 2022

1 minute read

UBS analyst Taylor McGinnis maintains Five9 (NASDAQ:FIVN) with a Buy and lowers the price target from $180 to $135.

InvenTrust Properties Corp. Announces The Appointment Of Julian E. Whitehurst To Chairperson Of The Board

By Benzinga Newsdesk

November 9, 6:35 PM

InvenTrust Properties Corp. ("InvenTrust" or the "Company") (NYSE:IVT) today announced that Julian (Jay) E. Whitehurst has been unanimously appointed to Chairperson of InvenTrust's Board of the Directors. Mr. Whitehurst

IVT

Co-Diagnostics, Inc. Appoints Richard Abbott As President, Concurrent With The Co Naming David Nielsen To Be Its Chief Operations Officer

By Benzinga Newsdesk

April 4, 9:31 AM

Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that last month

CODX

News

Zebra Technologies Demonstrates Generative AI On Devices Powered By Qualcomm

By Benzinga Newsdesk

October 4, 8:20 AM

GenAI on Zebra devices can offer new levels of privacy, security, capability and cost savings for businessesZebra Technologies Corporation (NASDAQ:ZBRA), a leading digital solution provider enabling businesses to

QCOM